AI IntelligenceMay 13, 2026Primary Market
Article
Isomorphic Labs · $2.1B · Unbekannt
Isomorphic Labs, a startup spun out of Google DeepMind that uses AI for drug discovery, has landed a $2.1 billion investment. CEO Demis Hassabis called it a 'massive vote of confidence' in AI-driven drug development. The capital will accelerate research and expand therapeutic pipelines.
Data Cube AI EditorialSource: Tech.eu
01
Source Brief
Isomorphic Labs, a startup spun out of Google DeepMind that uses AI for drug discovery, has landed a $2.1 billion investment. CEO Demis Hassabis called it a 'massive vote of confidence' in AI-driven drug development. The capital will accelerate research and expand therapeutic pipelines.
02